Another interesting point MT made was that very few of the patients coming out of MEND had been on the top dose of 10mg for any length of time, which makes the results even more compelling. Patients rolling over into the compassionate use program were on 6mg because the previous board did not anticipate a trial extension and had not manufactured sufficient drug. Patients on the OLE study are now on 10mg.
As an aside, you could hear the frustration in the voices of some board and management re. the previous board.
- Forums
- ASX - By Stock
- PAA
- Ann: Investor Briefings & Webinar Notice
Ann: Investor Briefings & Webinar Notice, page-71
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $82.65M |
Open | High | Low | Value | Volume |
16.0¢ | 17.0¢ | 15.5¢ | $145.3K | 876.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38307 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 302337 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38307 | 0.170 |
1 | 267747 | 0.165 |
2 | 325000 | 0.160 |
8 | 130434 | 0.155 |
15 | 371745 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 302337 | 3 |
0.180 | 269093 | 7 |
0.185 | 187500 | 3 |
0.190 | 243500 | 4 |
0.195 | 187936 | 6 |
Last trade - 15.51pm 23/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online